Skip to main content

Francis Laura's Form 4 filing

Shockwave Medical, Inc.SWAV · filed Mar 31, 2022

Accession no.
0001209191-22-021842
Filed
Mar 31, 2022
Trade date
Mar 29-31, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 15 non-derivative transactions and 2 derivative transactions. Open-market sales total $848.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Francis LauraCIK 0001218802Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 29, 2022Common StockMOption exerciseAcquired+2,310$6.59+$15,222.95,861Direct
Mar 29, 2022Common StockGGiftDisposed−2,310$0.00$03,551Direct
Mar 29, 2022Common StockGGiftAcquired+2,310$0.00$02,310Indirect
Mar 29, 2022Common StockSSaleDisposed−100$190.37F4−$19,0372,210Indirect
Mar 29, 2022Common StockSSaleDisposed−160$192.32F5−$30,771.22,050Indirect
Mar 29, 2022Common StockSSaleDisposed−180$193.93F6−$34,907.41,870Indirect
Mar 29, 2022Common StockSSaleDisposed−659$195.03F7−$128,524.771,211Indirect
Mar 29, 2022Common StockSSaleDisposed−769$195.91F8−$150,654.79442Indirect
Mar 29, 2022Common StockSSaleDisposed−300$197.20F9−$59,160142Indirect
Mar 29, 2022Common StockSSaleDisposed−120$198.14F10−$23,776.822Indirect
Mar 29, 2022Common StockSSaleDisposed−22$198.84F11−$4,374.480Indirect
Mar 31, 2022Common StockMOption exerciseAcquired+1,890$6.59+$12,455.15,441Direct
Mar 31, 2022Common StockGGiftDisposed−1,890$0.00$03,551Direct
Mar 31, 2022Common StockGGiftAcquired+1,890$0.00$01,890Indirect
Mar 31, 2022Common StockSSaleDisposed−1,890$210.00F12−$396,9000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 29, 2022Common StockMOption exerciseDisposed−2,310$0.00$018,080Direct
Mar 31, 2022Common StockMOption exerciseDisposed−1,890$0.00$016,190Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.99 to $190.65. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $191.91 to $192.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.39 to $194.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $194.45 to $195.43. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $195.50 to $196.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $196.63 to $197.60. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.72 to $198.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $198.79 to $199.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F12

All reported securities were sold at a price of $210.00.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)